The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Primary Care POC Diagnostics Market Progress Between 2026 And 2030?
The primary care poc diagnostics market size has shown substantial growth in recent years. It is anticipated to expand from $17.38 billion in 2025 to $18.59 billion in 2026, at a compound annual growth rate (CAGR) of 7.0%. The historical growth can be linked to factors including the increasing prevalence of infectious and chronic diseases, wider adoption of glucose and cardiometabolic testing, expansion of primary care diagnostic capabilities, increased use of otc diagnostic products, and improved accessibility of rapid tests.
The primary care poc diagnostics market size is anticipated to undergo significant expansion in the upcoming years, with projections indicating a rise to $24.6 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.3%. This expected growth over the forecast period is largely driven by factors such as the increasing demand for decentralized diagnostics, the rising integration of AI-enabled diagnostics, the expansion of telehealth-supported testing, a growing emphasis on preventive screening, and increased investments in personalized diagnostics. Noteworthy trends during this period include the increasing adoption of rapid diagnostic testing, the growing integration of digital poc devices, a rising demand for home-use diagnostic kits, the expansion of multiplex testing platforms, and an enhanced focus on early disease detection.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp
Which Factors Are Influencing The Growth Of The Primary Care POC Diagnostics Market?
The primary care POC diagnostics market is anticipated to experience growth driven by the rising prevalence of infectious diseases. These illnesses stem from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites and can spread between individuals either directly or indirectly through contaminated surfaces, air, water, or vectors like insects. Key contributors to the increased incidence of infectious diseases include poor environmental conditions, urbanization, antimicrobial resistance, and inadequate vaccination coverage. Primary care POC diagnostics serve as vital tools in addressing the spread of infectious diseases by facilitating early detection, enabling timely treatment, and supporting effective disease control measures in diverse healthcare settings. For instance, in March 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, tuberculosis cases rose from 9,622 in 2023 to 10,347 in 2024 (an 8% increase), with the incidence rate increasing from 2.9 to 3.0 per 100,000 population (a 6% rise). Therefore, the increasing prevalence of infectious diseases is a significant factor propelling the primary care POC diagnostics market.
How Is The Primary Care POC Diagnostics Market Segmented Across Different Segment Categories?
The primary care poc diagnostics market covered in this report is segmented –
1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products
2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses
Subsegments:
1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions
2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices
3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests
4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors
5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices
6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits
7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices
8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices
9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests
10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices
Which Trends Are Influencing Demand In The Primary Care POC Diagnostics Market?
Leading firms in the primary care POC diagnostics market are concentrating on creating sophisticated microfluidic-based rapid susceptibility testing solutions to improve the promptness of antibiotic treatment decisions. This testing method utilizes miniature fluidic pathways to swiftly isolate and cultivate bacteria, allowing for early determination of their reaction to various antimicrobials and shortening the result turnaround time. An example is Sysmex Corporation, a Japan-based diagnostic solutions firm, which introduced the PA-100 AST System, incorporating its patented microfluidic technology, in June 2023. The system is capable of detecting bacteria in urine samples in approximately 15 minutes and providing antimicrobial susceptibility test (AST) outcomes in as quickly as 30 minutes during a patient’s first clinic appointment. Its analyzer is compact and desktop-sized, designed to operate with reagent cartridges where samples are directly loaded for automated analysis. Medical practitioners lacking specialized laboratory training can effortlessly operate this device. Accelerating diagnostics, the instrument facilitates judicious antimicrobial prescription during initial patient consultations and contributes to the worldwide effort against antimicrobial resistance.
Which Organizations Play A Role In The Primary Care POC Diagnostics Market Landscape?
Major companies operating in the primary care poc diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.
Get The Full Primary Care POC Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report
Which Region Dominates The Primary Care POC Diagnostics Market By Market Share?
North America was the largest region in the primary care POC diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care poc diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Primary Care POC Diagnostics Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report
Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2026, By The Business Research Company
Direct Primary Care Market Report 2026
https://www.thebusinessresearchcompany.com/report/direct-primary-care-global-market-report
Direct Primary Care Market Report
https://www.thebusinessresearchcompany.com/report/direct-primary-care-global-market-report
Physician And Other Health Practitioner Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model